19 June 2025
Over the past two months, we’ve had the privilege of engaging with the healthcare communications and patient engagement communities at MAPS EMEA, ISMPP Annual, ISPOR US and Patients as Partners Europe. Across continents and conversations, one theme clearly stood out: patient involvement is no longer optional – it is essential.
Oxford PharmaGenesis showcased a broad range of HealthScience services throughout the ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis) meeting, held 7–10 October in Barcelona, Spain. ECTRIMS is the world’s largest annual international conference devoted to basic and clinical research in multiple sclerosis (MS), with this year’s edition attended by more than 9000…
Duchenne muscular dystrophy (DMD) is a progressive and ultimately fatal genetic muscle wasting disease that affects approximately 1 in 3500 newborn boys.1 A fault in the dystrophin gene prevents the production of the protein dystrophin, which is important for muscle structure and function.
The experience and insights of Oxford PharmaGenesis into founding its office in Basel are highlighted in a feature in the September issue of Director magazine (the publication of the UK Institute of Directors). The feature focuses on UK company expansion into Switzerland and includes quotes from an interview with Dr Richard White, Commercial Director of…
Today, employees at Oxford PharmaGenesis wore their jeans to support Jeans for Genes Day, helping to raise vital funds for children and families affected by genetic disorders. A ‘Bling my Jeans’ competition was held, which was adjudicated while staff enjoyed a delicious ‘all you can eat’ breakfast buffet.
Commercial Director of Oxford PharmaGenesis, Richard White, has completed the Prudential RideLondon-Surrey 100 cycle race to raise funds for VICTA (Visually Impaired Children Taking Action), a charity that supports blind and partially sighted children in the UK. Oxford PharmaGenesis matches donations raised by employees in events that support health-related causes.
Nearly 200 medical communications and pharma industry professionals worldwide tuned in yesterday to hear Oxford PharmaGenesis deliver a webinar on publication and communication of Real World Evidence (RWE). Commercial Director Richard White and Account Director Tim Koder presented the webinar as part the International Society of Medical Publications Professionals (ISMPP) online educational series, ISMPP University…
